TUMOR REVIEW 2013 Flashcards
Early stage esophageal cancer treatment
surgery alone
stage I and II
T1-2; N0-1
Up to T3 N0
workup for esophageal cancer
EUS - best
PET for distal mets
workup for gastric cancer
EGD
EUS
PET
treatment of T1 gastric cancer
surgery alone
treatment of T2 and greater gastric cancer
neoadjuvant chemotherapy:
plantar laparoscopy
implants are positive cells on washing abort
4-5 cm margin
D1 (slight benefit of D2 for long term survival) - increased morbidity
need 15 lymph nodes
careful, Colon and rectum 12
treatment of lymphoma of the stomach (not MALT)
chemotherapy:
CHOP
With or without Rituxan
functional reserve needed for hepatocellular carcinoma resection
20% functional if normal
40% functional child A./B.
best treatment for hepatocellular carcinoma and cirrhotic
transplant
Milan Criteria for transplant
no mass greater than 5 cm
if more than one lesion not greater than 3 cm and not more than 3 lesions total
no vascular invasion
no metastases
stage I gallbladder cancer
T1
Confined the mucosa
cholecystectomy alone
stage II gallbladder cancer
T2
Extent into muscularis propria
segment IVb and 5 resection
Node dissection
cholangiocarcinoma
intrahepatic:
Resection of possible
Transplant poor results
Extrahepatic: proximal third: hilar resection Lymph nodes In block liver resection include caudate
middle third:
Bile duct excision
Nodes
Frozen section of common bile duct margin
distal third
Whipple!
Best imaging to workup pancreatic cancer
triple phase CT scan
defined unresectable pancreatic cancer
SMA-did not have impingement
( SMA left and posterior to SMV)
SMV U./portal vein- CAN have abutment or encasement but they must be patent
borderline:
Abutment of the mass to SMA
short segment SMV occlusion
UNRESECTABLE:
Encasement of SMA
occlusion the portal vein
treatment unresectable pancreatic cancer
biliary drainage:
Gastro J
vs
stents if obstruction
Celiac ganglion block with alcohol
can’t be percutaneous or endoscopic
( for failed narcotics)
best overall test for neuroendocrine tumor of the pancreas and algorithm
chromogranin A
Neg:
he did not have in her endocrine tumor your done
order presentation of MEN 1 tumors
parathyroid hyperplasia 90% pituitary adenoma 66% ( angiofibroma 64%) pancreatic: Gastrinoma 50% ( more likely benign then when sporadic) insulinoma 20%
order presentation of MEN 2a
medullary thyroid cancer 100%
parathyroid hyperplasia and 50%
pheochromocytoma >33% ( possibly up to 50%)
order presentation of MEN 2b
medullary thyroid cancer 85-100%
mucosal neuroma 100%
pheochromocytoma 50%
best localization test for gastrinoma
octreotide scan
endoscopic ultrasound for pancreatic
endoluminal inspection and palpation for duodenal
can’t find insulinoma intraoperatively
venous sampling
surgical treatment for neuroendocrine tumors
less than 2 cm:
enucleate
greater than 2 cm:
resect- Whipple
medication to stabilize the patient with insulinoma
diazoxide
by screening test for carcinoid and subsequent algorithm
chromogranin A (same as screening test as pancreatic neuroendocrine tumor)
Pos:
5HIAA
preop medical management of carcinoid
octreotide-avoid serotonin syndrome
treatment of rectal carcinoid
just to enucleate
do not cause carcinoid syndrome
bronchopulmonary carcinoids
can get carcinoid syndrome-bypass liver
effects mitral valve
careful, abdominal carcinoma his affect tricuspid via drainage
algorithm for working up pheochromocytoma
chromogranin A positive
plasma free metanephrine x2
24-hour urine metanephrine
substances producing pheochromocytoma when adrenal medulla versus sympathetic chain
adrenal medulla:
Norepinephrine and epinephrine
sympathetic chain/extra-adrenal:
epinephrine only
localization test for pheochromocytoma
MIBG scan - analog norepinephrine
alpha blockers
phenoxybenzamine
prazosin
treatment of intraoperative hypertension during pheochromocytoma resection
nicardipine
short-acting beta blocker ( labetalol)
extrapancreatic manifestation of glucagonoma
migratory necrolytic erythema
where our glucagonomas found
body and tail
treatment of glucagonoma
if body or tail can excise it
colon Surveillance if polyp is excised
colonoscopy 3-5 years
if negative:
q 10 years
stage I colon cancer
T1
T2
stage II colon cancer
T3
T4
right colon cancers get chemotherapy
all stage III
high risk
includes stage IIB:
T4 lesion with invasion of extracolonic viscera
HNPCC
Lynch syndrome
Lynch 2:
uterus
Brain
Not breast?
FAP
APC
flex sig or colonoscope yearly
starting age 10-15 yo!
Desmoid tumors ( also seen in Gardner syndrome)
Duodenal cancer more likely after ileorectal anastomosis IJAA
because resorbed bile and ileal rectal anastomosis carcinogenic to the duodenum
medical treatment of FAP
nonsteroidal anti-inflammatories and a decrease polyp formation
Peutz-Jeghers syndrome
STK11 weird name weird gene tumor suppressor
early colectomy
mucosal pigmented
juvenile polyposis syndrome
BMPRIA and SMAD
dominant
only cancer of 10%
Cowden syndrome
PTEN mutation tumors or pressor gene
dominant
extracolonic: Breast Endometrial Thyroid Kidney Skin papillomas Neurologic - nonmalignant brain tumors
colorectal cancer
hematomas:
Mucous membranes mouth and nose and skin
benign breast disease
non-medullary thyroid cancer
multinodular goiters
serrated polyp syndrome
also called a sessile ulcerated polyp syndrome
premalignant
Path:
Edges serrated
Non-hyperchromic nuclei
most common sites:
CECUM
ASCENDING colon
inactivated APC gene
treatment:
Endoscopic excision
treatment of rectal cancer
formal resection
T1 and T2 node neg:
done
All others (T3 or any nodes): NEOadjuvant chemo and XRT
Adjuvant chemo and XRT: Capecitabine or 5FU / leucovorin 4500-5000 Gy
treatment of colorectal hepatic metastasis
treated simultaneously or stage
Neoadjuvant or adjuvant chemotherapy
Treatment of pulmonary colorectal metastases
more common with rectal
Consider resection